STAT

DECEMBER 19, 2024

The Food and Drug Administration on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will soon put a stop to companies making cheaper copies of the injection. The agency said it would give these compounders a grace period of 60 to 90 days before enforcing rules that would put a halt to their work, in an effort to avoid disruption for patients.

Compounding 232

Compounding Compounding Pharmacies Diabetes 232

PharmaVoice

DECEMBER 19, 2024

A new antibody from Merck would join a market teeming with new entries, but plenty of regulatory and financial uncertainty.

130

130

STAT

DECEMBER 19, 2024

Most of the formularies run by some of the largest health plans in the U.S. generally provide “fair access” to 11 treatments for several serious diseases, although transparent coverage information is often lacking for some medicines, a new analysis has found. Almost uniformly, the 11 formularies made the drugs available fairly when judged on three criteria: eligibility based on clinical data, restrictions placed on prescribers, and step therapy, which requires patients to try other

Department of Veterans Affairs 226

Department of Veterans Affairs Diabetes Drug Pricing 226

pharmaphorum

DECEMBER 19, 2024

At its third attempt, Mesoblast has secured FDA approval for the first-ever mesenchymal stem cell (MSC) therapy, Ryoncil for acute GvHD in children.

96

96

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

DECEMBER 19, 2024

CVS Health was accused of contributing to a nationwide epidemic of opioid addiction and overdose by filling illegal opioid prescriptions and billing federal health insurance programs, according to a lawsuit unsealed Wednesday by the U.S. Department of Justice. The lawsuit alleged that, since October 2013, CVS knowingly filled prescriptions for “dangerous and excessive quantities” of controlled substances that lacked a legitimate medical purpose, were not valid, and were not issued

Controlled Substances 175

Controlled Substances 175

The Pharmacist

DECEMBER 19, 2024

The drug atomoxetine and stimulants are the most effective treatments for adults with attention deficit hyperactivity disorder (ADHD), a new study has found. Researchers said their landmark systematic review, which included over 14,800 participants, sets a new benchmark for treatment of ADHD, and should inform future guidelines. However, they noted that the studys applicability to […] The post Atomoxetine and stimulants best treatments for adult ADHD, study suggests appeared first on The P

93

93

Express Pharma

DECEMBER 19, 2024

Lonza, a global manufacturing partner for the pharmaceutical, biotech, and nutraceutical sectors, has announced capacity expansions at its facilities in Rewari, India, and Suzhou, China. The expansion includes additional hard gelatin capsule (HGC) production lines to support the manufacture of high-quality capsules for the pharmaceutical and nutraceutical industries.

Dosage 84

Dosage 84

STAT

DECEMBER 19, 2024

Gilead Sciences will no longer provide four HIV medicines for free as part of a patient assistance program starting at the end of January, alarming community activists who worry the move will limit access and, consequently, impede nationwide efforts to combat the infectious disease. The list includes Truvada, a widely prescribed medicine that is used to treat and prevent HIV, but for which lower-cost generic versions are now available.

Pharmaceutical Companies 206

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing Drug Development 206

pharmaphorum

DECEMBER 19, 2024

Novo Holdings' $16.

83

83

STAT

DECEMBER 19, 2024

Top of the morning to you, and a fine one it is. Clear blue skies and chilly breezes are wafting across the Pharmalot campus, where the official mascots are snoozing after foraging for their breakfast. This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups of stimulation. Our choice today is blueberry cobbler.

Department of Veterans Affairs 141

Department of Veterans Affairs 141

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Express Pharma

DECEMBER 19, 2024

CPHI & PMEC India 2024 concluded successfully at the India Expo Centre in Greater Noida, Delhi-NCR, from November 26th to 28th. The three-day event brought together pharmaceutical innovations in machinery, analytical instruments, laboratory technologies, equipment, and ingredients. With over 60,000 attendees from 120 countries and more than 2,000 exhibitors, the event set new records for participation and exhibits.

Pharmaceutical Manufacturing 66

Pharmaceutical Manufacturing 66

pharmaphorum

DECEMBER 19, 2024

Neuralink rival Precision Neurosciences raises $102m for its brain-computer interface tech, plus financings for Redesign, DeepLife, TG0 and Tuva.

75

75

BioPharma Dive

DECEMBER 19, 2024

The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a limited grace period before taking any enforcement actions.

Compounding Pharmacies 71

Compounding Pharmacies Compounding 71

Express Pharma

DECEMBER 19, 2024

Antibiotics have long been essential in treating common infections and supporting complex medical interventions like surgeries, cancer chemotherapy, and organ transplants. However, the misuse and overuse of these critical drugs have catalysed a global health crisis: antimicrobial resistance (AMR). The 2023 annual report from the Indian Council of Medical Research (ICMR) has raised an alarm (1) , revealing increasing antibiotic resistance for common infections, including urinary tract infections

Pharmaceutical Companies 71

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Chemotherapy 71

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

STAT

DECEMBER 19, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. This is my last newsletter this year. Meghana will be writing the one tomorrow, and then we will be off for the next two weeks. Wishing everyone happy holidays and I’ll see you in the new year.

Drug Pricing 102

Drug Pricing Drug Development 102

pharmaphorum

DECEMBER 19, 2024

Ottimo raises $140m for PD-1 and VEGF-targeting jankistomig, which the startup says is differentiated from bispecific antibodies in the class.

64

64

BioPharma Dive

DECEMBER 19, 2024

An startup formed by KdT Ventures intends to test the drug, which was once licensed to Merck and evaluated in multiple metabolic disorders, for an unspecified rare conditon.

59

59

pharmaphorum

DECEMBER 19, 2024

A trial of Vertex's suzetrigine in neuropathic back pain met its primary objective, but shares in the company fell as investors reacted to the data

59

59

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

BioPharma Dive

DECEMBER 19, 2024

The company is planning a “broad Phase 3 program” for two anticoagulants after they outperformed marketed medicines in a pair of mid-stage trials.

59

59

pharmaphorum

DECEMBER 19, 2024

Novartis has confirmed it will shut down two MorphoSys sites in Germany and the US, with the loss of around 330 jobs, by the end of next year.

59

59

Pharmaceutical Technology

DECEMBER 19, 2024

Vertex said the Phase II trial met its primary endpoint, however there was only a minor difference to placebo.

59

59

BioPharma Dive

DECEMBER 19, 2024

While the pharma is still developing a MorphoSys drug acquired in its $2.9 billion deal for the biotech, it is closing down sites in the U.S. and Germany.

59

59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

DECEMBER 19, 2024

Mesoblast has gained US FDA approval for its mesenchymal stromal cell (MSC) therapy, Ryoncil (remestemcel-L), to treat SR-aGvHD.

59

59

BioPharma Dive

DECEMBER 19, 2024

Mixed results from a study focused on lower back pain left analysts wanting as well as confused about Vertex's plans to forge ahead in the indication.

59

59

Pharmaceutical Technology

DECEMBER 19, 2024

BioAge Labs has entered a multi-year research partnership with Novartis to seek therapeutic drug targets for ageing-related conditions.

59

59

pharmaphorum

DECEMBER 19, 2024

Roche and Prothena's alpha-synuclein-targeting prasinezumab for Parkinson's fails again, leaving them sifting through the data for efficacy signals

58

58

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharmaceutical Technology

DECEMBER 19, 2024

MSD has entered an exclusive global licence agreement with Hansoh Pharma for a preclinical oral small molecule GLP-1RA.

59

59

European Pharmaceutical Review

DECEMBER 19, 2024

With the life sciences and healthcare sectors increasing integration of artificial intelligence (AI) into their infrastructure, according to research by GlobalData, one-third of healthcare professionals considered data privacy is the primary obstacle, citing challenges such as robust safeguards, workflow integration, and stakeholder acceptance [being] essential to ensure AIs ethical implementation and long-term success. 1 These concerns are held alongside the promise of this technology and its p

Drug Development 52

Drug Development 52

Pharmaceutical Technology

DECEMBER 19, 2024

Novo Holdings has completed the previously announced acquisition of Catalent in an all-cash transaction valued at around $16.5bn.

59

59

Outsourcing Pharma

DECEMBER 19, 2024

Gilead teams up with Terray for AI-powered drug discovery, leveraging Terrays tNova platform to accelerate the development of innovative treatments through generative AI and lab experiments.

56

56

The Pharmacist

DECEMBER 19, 2024

The launch of Pharmacy First in England this year was hailed a significant milestone for the sector and a game-changer for increasing patient access to healthcare. Pharmacies across the country have stepped up to the task, providing thousands of consultations and countless support to patients. But it has not come without its challenges. It started […] The post Pharmacy First: A year of the service in England appeared first on The Pharmacist.

59

59